Voyager Therapeutics
VYGR
VYGR
75 hedge funds and large institutions have $233M invested in Voyager Therapeutics in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
44% more funds holding
Funds holding: 52 → 75 (+23)
1.28% more ownership
Funds ownership: 40.78% → 42.06% (+1.3%)
Holders
75
Holding in Top 10
–
Calls
$3.61M
Puts
$21K
Top Buyers
| 1 | +$5.88M | |
| 2 | +$5.57M | |
| 3 | +$5.38M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$5.16M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$4.88M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$9.37M | |
| 3 | -$1.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.35M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.32M |